QuidelOrtho Corp. Hits Day High with Strong 10.99% Intraday Surge

QuidelOrtho Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant uptick in its stock price, gaining 10.99% on September 30, 2025. The stock reached an intraday high of USD 29.51, marking a notable moment in its trading activity.
Despite this day's performance, QuidelOrtho has faced challenges over the longer term, with a one-year performance decline of 33.34%, contrasting sharply with the S&P 500's gain of 16.09% during the same period. The company's financial metrics reveal a pre-tax profit of USD -50.7 million, reflecting a substantial drop of 138.31%. Additionally, the interest expense has increased by 39.51%, indicating rising financial burdens.

QuidelOrtho's return on equity stands at -3.37%, and its price-to-book ratio is 0.69, suggesting that the stock is trading below its book value. The company has reported negative results for the last 12 consecutive quarters, contributing to its consistent underperformance against the benchmark. As it navigates these financial dynamics, the recent stock activity highlights a momentary rebound amidst ongoing challenges.